Regeneron Pharmaceuticals (REGN) Return on Sales [ROS] (2009 - 2026)
Regeneron Pharmaceuticals (REGN) recorded Return on Sales [ROS] of 30.15% in Q2 2026, up 0.78 percentage points from 29.37% a year earlier and up 12.32 percentage points from the prior quarter.
Powered by 
Analysis
Regeneron Pharmaceuticals (REGN) Return on Sales [ROS] (2009 - 2026) Analysis & Trends
On a TTM basis, Regeneron Pharmaceuticals' Return on Sales [ROS] came in at 24.74% as of Jun 30, 2026, down 2.28 percentage points year-over-year; for FY2025, it was 24.95%, down 3.15 percentage points from FY2024.
- Annual Return on Sales [ROS] has declined for four straight years, with a five-year change of -17.15 percentage points (FY2020 to FY2025).
- Across earlier years, Return on Sales [ROS] came in at 28.10% in FY2024 (-2.75 pp), 30.85% in FY2023 (-8.08 pp), 38.93% in FY2022 (-16.74 pp) and 55.67% in FY2021 (+13.58 pp).
- The Q2 2026 figure is the highest quarterly Return on Sales [ROS] since Q3 2024.
- On a year-over-year basis, Return on Sales [ROS] rose in 1 of the last eight quarters, with an average year-over-year change of -2.18 percentage points.
- Peak year-over-year performance for Return on Sales [ROS] in the last five years was a gain of 7.59 percentage points in Q3 2021, against a drop of 26.29 percentage points in Q2 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at 17.83% (Q1 2026), 22.65% (Q4 2025) and 27.35% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn | 28.37% |
| 10 | Regeneron Pharmaceuticals | 81.27 Bn | 47.47 Bn | 3.71 Bn | 30.15% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 30.15% |
| Mar 31, 2026 | 17.83% |
| Dec 31, 2025 | 22.65% |
| Sep 30, 2025 | 27.35% |
| Jun 30, 2025 | 29.37% |
| Mar 31, 2025 | 19.54% |
| Dec 31, 2024 | 26.13% |
| Sep 30, 2024 | 31.70% |
| Jun 30, 2024 | 30.15% |
| Mar 31, 2024 | 23.89% |
| Dec 31, 2023 | 28.33% |
| Sep 30, 2023 | 33.04% |
| Jun 30, 2023 | 32.19% |
| Mar 31, 2023 | 29.94% |
| Dec 31, 2022 | 33.59% |
| Sep 30, 2022 | 41.68% |
| Jun 30, 2022 | 38.85% |
| Mar 31, 2022 | 42.44% |
| Dec 31, 2021 | 53.31% |
| Sep 30, 2021 | 53.50% |
API Access
Regeneron Pharmaceuticals Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=REGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "REGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=REGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();